| Ipca Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
|
|
|
|
|
|
|
|
| Mar'2025 | Mar'2024 | Mar'2023 | Mar'2022 | Mar'2021 | |
|---|---|---|---|---|---|
| SOURCES OF FUNDS : | |||||
| Equity Share Capital | 25.37 | 25.37 | 25.37 | 25.37 | 25.37 |
| Reserves | 6,866.25 | 6,323.34 | 5,851.93 | 5,450.39 | 4,727.35 |
| Equity Share Warrants | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Application Money | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Shareholders Funds | 6,891.62 | 6,348.71 | 5,877.30 | 5,475.76 | 4,752.72 |
| Secured Loans | 726.41 | 990.54 | 857.91 | 554.57 | 113.53 |
| Unsecured Loans | 179.82 | 161.28 | 582.47 | 221.84 | 122.72 |
| Total Debt | 906.23 | 1,151.82 | 1,440.38 | 776.41 | 236.25 |
| Other Liabilities | 57.76 | 50.61 | 46.85 | 44.33 | 39.44 |
| Total Liabilities | 7,855.61 | 7,551.14 | 7,364.53 | 6,296.50 | 5,028.41 |
| APPLICATION OF FUNDS : | |||||
| Gross Block | 4,387.79 | 4,165.82 | 3,889.09 | 3,364.68 | 2,899.27 |
| Less: Accumulated Depreciation | 1,850.82 | 1,642.12 | 1,410.43 | 1,211.59 | 1,030.67 |
| Less:Impairment of Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Block | 2,536.97 | 2,523.70 | 2,478.66 | 2,153.09 | 1,868.60 |
| Lease Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Capital Work in Progress | 489.65 | 175.20 | 123.02 | 297.15 | 182.00 |
| Investments | 2,693.26 | 2,654.16 | 1,056.73 | 1,338.70 | 867.84 |
| Current Assets, Loans & Advances | |||||
| Inventories | 1,542.39 | 1,677.09 | 1,660.13 | 1,779.54 | 1,517.09 |
| Sundry Debtors | 1,154.61 | 1,027.40 | 925.90 | 824.30 | 774.46 |
| Cash and Bank Balance | 164.53 | 112.92 | 1,706.06 | 595.50 | 306.92 |
| Loans and Advances | 266.47 | 281.88 | 259.74 | 305.81 | 285.49 |
| Total Current Assets | 3,128.00 | 3,099.29 | 4,551.83 | 3,505.15 | 2,883.96 |
| Less : Current Liabilities and Provisions | |||||
| Current Liabilities | 849.44 | 782.48 | 773.37 | 866.28 | 733.57 |
| Provisions | 174.67 | 142.56 | 129.62 | 117.15 | 113.15 |
| Total CL & Provisions | 1,024.11 | 925.04 | 902.99 | 983.43 | 846.72 |
| Net Current Assets | 2,103.89 | 2,174.25 | 3,648.84 | 2,521.72 | 2,037.24 |
| Miscellaneous Expenses not written off | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax Assets | 34.69 | 23.17 | 18.52 | 101.48 | 88.44 |
| Deferred Tax Liability | 225.89 | 206.26 | 197.97 | 259.99 | 223.44 |
| Net Deferred Tax | -191.20 | -183.09 | -179.45 | -158.51 | -135.00 |
| Other Assets | 223.04 | 206.92 | 236.73 | 144.35 | 207.73 |
| Total Assets | 7,855.61 | 7,551.14 | 7,364.53 | 6,296.50 | 5,028.41 |
| Contingent Liabilities | 116.38 | 124.51 | 1,996.35 | 103.39 | 86.68 |